{"database":"PeptideAtlas","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Raw":["ftp://ftp.peptideatlas.org/pub/PeptideAtlas/Repository/Halobacterium/PAe000224/PAe000224_RAW.tar"],"Other":["ftp://ftp.peptideatlas.org/pub/PeptideAtlas/Repository/Halobacterium/PAe000224/PAe000224_README","ftp://ftp.peptideatlas.org/pub/PeptideAtlas/Repository/Halobacterium/PAe000224/PAe000224_mzXML_201104181135.tar.gz","ftp://ftp.peptideatlas.org/pub/PeptideAtlas/Repository/Halobacterium/PAe000224/PAe000224_mzXML_201104181135.properties","ftp://ftp.peptideatlas.org/pub/PeptideAtlas/Repository/Halobacterium/PAe000224/PAe000224_222_sequest.params","ftp://ftp.peptideatlas.org/pub/PeptideAtlas/Repository/Halobacterium/PAe000224/PAe000224_prot_222_201104181135.properties","ftp://ftp.peptideatlas.org/pub/PeptideAtlas/Repository/Halobacterium/PAe000224/PAe000224_Search_Results_222_201104181135.tar.gz","ftp://ftp.peptideatlas.org/pub/PeptideAtlas/Repository/Halobacterium/PAe000224/PAe000224_Search_Results_222_201104181135.properties","ftp://ftp.peptideatlas.org/pub/PeptideAtlas/Repository/Halobacterium/PAe000224/PAe000224_prot_222_201104181135.tar.gz","ftp://ftp.peptideatlas.org/pub/PeptideAtlas/Repository/Halobacterium/PAe000224/PAe000224_222_search.params.tar.gz"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"submitter":["Y. A. Goo, E. C. Yi, N. S. Baliga, W. A. Tao, M. Pan, R. Aebersold, D. R. Goodlett, L. Hood and W. V. Ng"],"disease":[""],"software":["TPP"],"full_dataset_link":["'https://db.systemsbiology.net/sbeams/cgi/PeptideAtlas/ManageTable.cgi?TABLE_NAME=AT_sample&sample_id=251'"],"synonyms":[""],"submitter_email":["","nbaliga@systemsbiology.org"],"repository":["PeptideAtlas"],"sample_protocol":[""],"data_protocol":[""],"omics_type":["Proteomics"],"pubmed":[""],"instrument_platform":["Unknown"],"project_tag":[""],"species":["Halobacterium Nrc-1 (halobacterium)"],"publication":[""],"pubmed_abstract":["This paper reports on the findings of the Biomedical Research Institute, as one of the participants in the pilot study of the HUPO Brain Proteome Project. A biopsy and autopsy study sample derived from human brain was distributed among the participants for proteomic analysis. In our laboratory, attention was focused on protein identification using the bottom-up shotgun approach. Protein extracts derived from both samples were trypsinized and analyzed separately by 2-D LC and MS. In a complementary approach, the tryptic digests were analyzed directly by LC-ESI-MS/MS and gas-phase fractionation in the mass spectrometer. Taken together, both proteomic approaches in combination with a stringent evaluation process, resulted in the confident identification of 209 proteins in the human brain samples under investigation."],"pubmed_title":["Gel-free analysis of the human brain proteome: application of liquid chromatography and mass spectrometry on biopsy and autopsy samples."],"pubmed_authors":["Dumont Debora D, Noben Jean-Paul JP, Verhaert Peter P, Stinissen Piet P, Robben Johan J"],"additional_accession":[]},"is_claimable":false,"name":"YAGsn1","description":"enrichment for soluble proteins; Goo et al., 2003, Mol Cell Proteomics 2(8):505","dates":{"publication":"2006-12-31","export":"2016-03-29"},"accession":"PAe000224","cross_references":{"pubmed":["16912970"],"taxonomy":["64091"]}}